Atiprimod is an inhibitor of cancer cell proliferation and angiogenesis.
Saved in:
| Title: | Atiprimod is an inhibitor of cancer cell proliferation and angiogenesis. |
|---|---|
| Authors: | Shailubhai K; Callisto Pharmaceuticals, Inc, 420 Lexington Avenue, Suite 1609, New York, NY 10170, USA. shailu@callistopharma.com, Dheer S, Picker D, Kaur G, Sausville EA, Jacob GS |
| Source: | Journal of experimental therapeutics & oncology [J Exp Ther Oncol] 2004 Dec; Vol. 4 (4), pp. 267-79. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: | Publisher: Old City Publishing Country of Publication: United States NLM ID: 9604933 Publication Model: Print Cited Medium: Print ISSN: 1359-4117 (Print) Linking ISSN: 13594117 NLM ISO Abbreviation: J Exp Ther Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
